Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   

The Angels Initiative

Stroke prevention

  Chronic Heart Failure

  Free Subscription


3 Am Heart J
1 Cardiovasc Res
2 Clin Cardiol
2 Eur J Heart Fail
2 Int J Cardiol
5 J Cardiovasc Pharmacol
8 J Mol Cell Cardiol
1 PLoS One

  Retrieve available abstracts of this week’s articles:
HTML format
Single Articles

    Am Heart J

  1. LOPEZ-GALVEZ R, Marin F, Rivera-Caravaca JM
    Predicting heart failure in atrial fibrillation patients: What about using biomarkers?
    Am Heart J. 2022 May 7. pii: S0002-8703(22)00092.

  2. GILSTRAP L, Zipkin RJ, Barnes JA, King A, et al
    Sacubitril/Valsartan vs. ACEi/ARB at Hospital Discharge and 5-Year Survival in Older Patients with Heart Failure with Reduced Ejection Fraction: A Decision Analysis Approach.
    Am Heart J. 2022 May 4. pii: S0002-8703(22)00082.
    PubMed         Abstract available

  3. JENSEN J, Omar M, Ali M, Frederiksen PH, et al
    The Effect of Empagliflozin on Contractile Reserve in Heart Failure: Prespecified Sub-Study of a Randomized, Double-Blind, and Placebo-Controlled Trial.
    Am Heart J. 2022 May 2. pii: S0002-8703(22)00083.
    PubMed         Abstract available

    Cardiovasc Res

  4. ROUHI L, Fan S, Cheedipudi SM, Braza-Boils A, et al
    The EP300/TP53 pathway, a suppressor of the Hippo and canonical WNT pathways, is activated in human hearts with arrhythmogenic cardiomyopathy in the absence of overt heart failure.
    Cardiovasc Res. 2022;118:1466-1478.
    PubMed         Abstract available

    Clin Cardiol

  5. WANG T, Yu FC, Wei Q, Xu X, et al
    Sleep-disordered breathing in heart failure patients with different etiologies.
    Clin Cardiol. 2022 May 10. doi: 10.1002/clc.23840.
    PubMed         Abstract available

  6. GU G, Wu J, Gao X, Liu M, et al
    Catheter ablation of atrial fibrillation in patients with heart failure and preserved ejection fraction: A meta-analysis.
    Clin Cardiol. 2022 May 11. doi: 10.1002/clc.23841.
    PubMed         Abstract available

    Eur J Heart Fail

    Intravenous iron in heart failure with reduced ejection fraction: just about right.
    Eur J Heart Fail. 2022 Apr 28. doi: 10.1002/ejhf.2520.

  8. CARTER S, Hendren NS, Grodin JL
    Sodium-glucose cotransporter 2 inhibition, uric acid, and heart failure: correlation without causation?
    Eur J Heart Fail. 2022 Apr 29. doi: 10.1002/ejhf.2516.

    Int J Cardiol

  9. IWATSU K, Ikeda T, Matsumura K, Ashikawa H, et al
    Gap in the prognostic impact of short physical performance battery among phenotypes of heart failure.
    Int J Cardiol. 2022 May 6. pii: S0167-5273(22)00656.
    PubMed         Abstract available

  10. ANGUITA E, Chaparro A, Candel FJ, Ramos-Acosta C, et al
    Biomarkers of stable and decompensated phases of heart failure with preserved ejection fraction.
    Int J Cardiol. 2022 May 6. pii: S0167-5273(22)00655.
    PubMed         Abstract available

    J Cardiovasc Pharmacol

  11. AL-ANI MA, Murray MR, Taha MB, Meece L, et al
    Impact of Laparoscopic Sleeve Gastrectomy on Cardiovascular Pharmacotherapy in Left Ventricular Assist Device Patients.
    J Cardiovasc Pharmacol. 2022 Jan 17. pii: 00005344-900000000-98060.
    PubMed         Abstract available

  12. BILLINGSLEY H, Dixon D, Yehya A, Carbone S, et al
    Sleeve Gastrectomy Reduces BMI and Pill Count in Patients With LVAD.
    J Cardiovasc Pharmacol. 2022;79:644-645.

  13. OYESOMI ET, Tabrizchi R
    Heart and Sodium-Glucose Cotransporter 2 Inhibitors: A Sodium Dilemma.
    J Cardiovasc Pharmacol. 2022;79:641-643.

  14. GUO Y, Xiao C, Zhao K, He Z, et al
    Physical Exercise Modalities for the Management of Heart Failure With Preserved Ejection Fraction: A Systematic Review and Meta-Analysis.
    J Cardiovasc Pharmacol. 2022;79:698-710.
    PubMed         Abstract available

    Development and Current Role of Sodium Glucose Cotransporter Inhibition in Cardiorenal Metabolic Syndrome.
    J Cardiovasc Pharmacol. 2022;79:593-604.
    PubMed         Abstract available

    J Mol Cell Cardiol

  16. STENZIG J, Lemoine MD, Stoter AMS, Wrona KM, et al
    Recapitulation of dyssynchrony-associated contractile impairment in asymmetrically paced engineered heart tissue.
    J Mol Cell Cardiol. 2022;163:97-105.
    PubMed         Abstract available

  17. ESCHENHAGEN T, Ridders K, Weinberger F
    How to repair a broken heart with pluripotent stem cell-derived cardiomyocytes.
    J Mol Cell Cardiol. 2022;163:106-117.
    PubMed         Abstract available

  18. CAGGIANO LR, Holmes JW, Witzenburg CM
    Individual variability in animal-specific hemodynamic compensation following myocardial infarction.
    J Mol Cell Cardiol. 2021 Oct 28. pii: S0022-2828(21)00207.
    PubMed         Abstract available

  19. TANI H, Tohyama S, Kishino Y, Kanazawa H, et al
    Production of functional cardiomyocytes and cardiac tissue from human induced pluripotent stem cells for regenerative therapy.
    J Mol Cell Cardiol. 2022;164:83-91.
    PubMed         Abstract available

  20. WANG N, Dries E, Fowler ED, Harmer SC, et al
    Inducing Ito,f and phase 1 repolarization of the cardiac action potential with a Kv4.3/KChIP2.1 bicistronic transgene.
    J Mol Cell Cardiol. 2022;164:29-41.
    PubMed         Abstract available

  21. QIU Y, Pan X, Chen Y, Xiao J, et al
    Hallmarks of exercised heart.
    J Mol Cell Cardiol. 2022;164:126-135.
    PubMed         Abstract available

  22. WANG C, Zhang Y, Methawasin M, Braz CU, et al
    RBM20(S639G) mutation is a high genetic risk factor for premature death through RNA-protein condensates.
    J Mol Cell Cardiol. 2022;165:115-129.
    PubMed         Abstract available

  23. CHENG G, Zhu D, Huang K, Caranasos TG, et al
    Minimally invasive delivery of a hydrogel-based exosome patch to prevent heart failure.
    J Mol Cell Cardiol. 2022 May 3. pii: S0022-2828(22)00085.
    PubMed         Abstract available

    PLoS One

  24. SHARA N, Bjarnadottir MV, Falah N, Chou J, et al
    Voice activated remote monitoring technology for heart failure patients: Study design, feasibility and observations from a pilot randomized control trial.
    PLoS One. 2022;17:e0267794.
    PubMed         Abstract available

Thank you for your interest in scientific medicine.

AMEDEO Chronic Heart Failure is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.